April 26th, 2012
Earlier today, we held our Annual Meeting of Shareholders, hosting approximately 1,800 shareholders, retirees and employees in New Brunswick, N.J. You can watch a replay of the meeting on our website and read a recap of the voting results in an earlier blog post by our Corporate Secretary, Doug Chia.
This was my first opportunity to attend the meeting in person, but that wasn’t the only reason it was a historic event! Johnson & Johnson welcomed its seventh CEO in our history as Alex Gorsky assumed responsibility of incoming CEO from Bill Weldon, who will remain Chairman of the Board. It was a unique honor to be present for the transition from Mr. Weldon, who has led Johnson & Johnson steadfastly for the past 10 years to Mr. Gorsky, who promised to “bring all my heart and soul to the role of CEO.” As he passed the leadership mantle, Weldon remarked that he is “confident that Johnson & Johnson will continue shaping and leading the future of health care and advancing the health and well being of people around the world.”
You can read more about our history of leadership on the Kilmer House blog.
Although the transition of leadership was the highlight of the meeting, we also shared news and notable achievements from our three business sectors, as well as looked ahead to Johnson & Johnson’s next chapter. In addition, we announced that Johnson & Johnson will raise the quarterly dividend to shareholders for the 50th consecutive year.